{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "10950388",
  "DateCompleted": {
    "Year": "2000",
    "Month": "12",
    "Day": "07"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "12",
    "Day": "13"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0956-3202",
      "JournalIssue": {
        "Volume": "11",
        "Issue": "4",
        "PubDate": {
          "Year": "2000",
          "Month": "Jul"
        }
      },
      "Title": "Antiviral chemistry & chemotherapy",
      "ISOAbbreviation": "Antivir Chem Chemother"
    },
    "ArticleTitle": "Antiviral therapy for enteroviruses and rhinoviruses.",
    "Pagination": {
      "StartPage": "261",
      "EndPage": "271",
      "MedlinePgn": "261-71"
    },
    "Abstract": {
      "AbstractText": [
        "The picornaviruses are a diverse group of viral pathogens that together comprise the most common causes of infection of humans in the developed world. Within the picornavirus family are three well-known groups of human pathogens--the rhinoviruses, the enteroviruses (including polioviruses, coxsackieviruses and echoviruses) and the hepatoviruses (including hepatitis A virus). This article will focus on the rhinoviruses and enteroviruses, agents for which substantial effort has been expended, and recent successes reported, toward the development of safe and effective antiviral therapy."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "University of Colorado School of Medicine, Department of Pediatrics, Denver, USA. harley.rotbart@UCHSC.edu"
          }
        ],
        "LastName": "Rotbart",
        "ForeName": "H A",
        "Initials": "HA"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Antivir Chem Chemother",
    "NlmUniqueID": "9009212",
    "ISSNLinking": "0956-3202"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Benzimidazoles"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Immunoglobulins, Intravenous"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Oximes"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Sulfonamides"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Viral Proteins"
    },
    {
      "RegistryNumber": "9008-11-1",
      "NameOfSubstance": "Interferons"
    },
    {
      "RegistryNumber": "EC 3.4.22.-",
      "NameOfSubstance": "Cysteine Endopeptidases"
    },
    {
      "RegistryNumber": "EC 3.4.22.28",
      "NameOfSubstance": "3C Viral Proteases"
    },
    {
      "RegistryNumber": "I5V34WG2BE",
      "NameOfSubstance": "viroxime"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "3C Viral Proteases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Benzimidazoles"
    },
    {
      "QualifierName": [
        "antagonists & inhibitors"
      ],
      "DescriptorName": "Capsid"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Line"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [
        "chemistry"
      ],
      "DescriptorName": "Cysteine Endopeptidases"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Resistance, Microbial"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Enterovirus"
    },
    {
      "QualifierName": [
        "drug therapy",
        "virology"
      ],
      "DescriptorName": "Enterovirus Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Immunoglobulins, Intravenous"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Interferons"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Molecular Structure"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Oximes"
    },
    {
      "QualifierName": [
        "drug therapy",
        "virology"
      ],
      "DescriptorName": "Picornaviridae Infections"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Rhinovirus"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Sulfonamides"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Viral Proteins"
    }
  ],
  "NumberOfReferences": "121"
}